Publications

• Differential Proteomic Expression of Equine Cardiac and Lamellar Tissue During Insulin-Induced Laminitis 
  A Campolo, M Frantz, MA de Laat, SD Hartson, MO Furr, VA Lacombe. Frontiers in Veterinary Science 7, 308 2020

• Glial Growth Factor 2 Regulates Glucose Transport in Healthy Cardiac Myocytes and During Myocardial Infarction via an Akt-Dependent Pathway
  S Shoop, Z Maria, A Campolo, N Rashdan, D Martin, P Lovern, VA Lacombe. Frontiers in Physiology 10, 189 2 2019

• Adverse Metabolic Effects of Diltiazem Treatment During Diabetic Cardiomyopathy
  M Parriman, A Campolo, AP Waller, VA Lacombe. Journal of cardiovascular pharmacology and therapeutics 24 (2), 193-203 2019

• Dysregulation of insulin-sensitive glucose transporters during insulin resistance-induced atrial fibrillation.
  Maria Z, Campolo AR, Scherlag BJ, Ritchey JW, Lacombe VA. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt A):987-996.
• Quantification of Cell-Surface Glucose Transporters in the Heart Using a Biotinylated Photolabeling Assay.
  Maria Z, Lacombe VA. Methods Mol Biol. 2018;1713:229-240.
• Prolonged hyperinsulinemia affects metabolic signal transduction markers in a tissue specific manner.
  Campolo A, de Laat MA, Keith L, Gruntmeir KJ, Lacombe VA. Domest Anim Endocrinol. 2016 Apr;55:41-5.
• Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria.
  Maria Z, Campolo AR, Lacombe VA. PLoS One. 2015 Dec 31;10(12):e0146033.
• Loss of Toll-Like Receptor 4 Function Partially Protects against Peripheral and Cardiac Glucose Metabolic Derangements During a Long-Term High-Fat Diet.
  Jackson EE, Rendina-Ruedy E, Smith BJ, Lacombe VA. PLoS One. 2015 Nov 5;10(11):e0142077.
• Sarcoplasmic reticulum Ca2+ ATPase pump is a major regulator of glucose transport in the healthy and diabetic heart.
  Waller AP, Kalyanasundaram A, Hayes S, Periasamy M, Lacombe VA. Biochim Biophys Acta. 2015 May;1852(5):873-81.
• Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart.
  de Laat MA, Gruntmeir KJ, Pollitt CC, McGowan CM, Sillence MN, Lacombe VA. Front Endocrinol (Lausanne). 2014 Jul 22;5:120.
• GLUT12 functions as a basal and insulin-independent glucose transporter in the heart.
  Waller AP, George M, Kalyanasundaram A, Kang C, Periasamy M, Hu K, Lacombe VA. Biochim Biophys Acta. 2013 Jan;1832(1):121-7.
• Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling.
  Kranstuber AL, Del Rio C, Biesiadecki BJ, Hamlin RL, Ottobre J, Gyorke S, Lacombe VA. Front Physiol. 2012 Jul 19;3:292.
• Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters.
  Ware B, Bevier M, Nishijima Y, Rogers S, Carnes CA, Lacombe VA. Am J Physiol Regul Integr Comp Physiol. 2011 Nov;301(5):R1300-6.
• Naturally occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissues without change in AS160 activation.
  Waller AP, Kohler K, Burns TA, Mudge MC, Belknap JK, Lacombe VA. Biochim Biophys Acta. 2011 Sep;1812(9):1098-103

Partial list of published work in Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/?term=lacombe+VA